Traditional Chinese Medicine Intervention for Ischemic Cerebrovascular Disease and Diabetes Mellitus: An Efficacy Comparative Study

Trial statusNot yet recruiting
Trial phasePhase 4
Trial typeInterventional
Biological sexAll
Age18+
SponsorGuangzhou University of Traditional Chinese Medicine

About this trial

The objective of this observational study is to understand the long-term effects of traditional Chinese medicine (TCM) intervention on patients with cerebral infarction onset within \<48 hours and comorbid diabetes. The primary question it aims to address is:

Can long-term TCM intervention for the treatment of ischemic cerebrovascular disease comorbid with diabetes improve patients' neurological deficits and self-care ability? Participants receiving TCM intervention (universal treatment combined with syndrome-specific treatment) as part of routine cerebrovascular disease management will undergo follow-up assessments at 30 days, 90 days, 6 months, and 12 months within 1 year to evaluate neurological status (e.g., mRS score, NIHSS score) and quality of life indicators.

Eligibility criteria

Qualifiers

Age ≥ 18 years old, regardless of gender.

Fasting blood glucose ≥ 7.0 mmol/L.

2-hour postprandial blood glucose ≥ 11.1 mmol/L.

Glycated hemoglobin ≥ 6.5%.

Disqualifiers

None

Trial design

Treatments tested in this trial

  • (Intensive treatment) Chuanzhi Tongluo Capsules
  • Standard Treatment (Guideline-Based)
  • (Sequential treatment) Chuanzhi Tongluo Capsules
  • TCM Syndrome Differentiation Decoction

Treatment groups

3,666 Participants
are divided into 2 treatment groups

Locations

This trial has no locations